Christopher Burge, 34, couldn't recall the last time he "felt 100%." Then he noticed bowel changes. Soon after, he was ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

Infections spread by sexual activity are known as sexually transmitted infections (STIs). An estimated 20% of Americans have ...

Christopher Burge is one of a growing number of young adults diagnosed with the disease, and hopes to spread awareness about the early signs.

“We found that the probability of being alive and free of disease at two years was approximately 64% for cetuximab versus 51% ...

Homi Bhabha Cancer Hospital and Research Centre in Mohali held its first donors' meet to honor public and corporate support for enhancing cancer care since its opening in August 2022. The event ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...